These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7924634)

  • 81. [TSH-receptor antibodies: immunoanalytical characteristics].
    Massart C
    Ann Biol Clin (Paris); 2015; 73(2):221-4. PubMed ID: 25847746
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Determination of TSH receptor antibodies--clinical value].
    Schifferdecker E; Schulz F; Schöffling K
    Klin Wochenschr; 1986 Jan; 64(1):8-14. PubMed ID: 2869183
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Mechanism of action of a nanomolar potent, allosteric antagonist of the thyroid-stimulating hormone receptor.
    van Koppen CJ; de Gooyer ME; Karstens WJ; Plate R; Conti PG; van Achterberg TA; van Amstel MG; Brands JH; Wat J; Berg RJ; Lane JR; Miltenburg AM; Timmers CM
    Br J Pharmacol; 2012 Apr; 165(7):2314-24. PubMed ID: 22014107
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Thyroid-stimulating hormone receptor antibody assays: recommendation for correct interpretation of results in Graves disease.
    Massart C; d'Herbomez M
    Clin Chem; 2013 May; 59(5):855. PubMed ID: 23396139
    [No Abstract]   [Full Text] [Related]  

  • 85. Structural analysis of the TSH receptor.
    Rees Smith B; Furmaniak J
    Horm Metab Res Suppl; 1990; 23():28-32. PubMed ID: 2210629
    [No Abstract]   [Full Text] [Related]  

  • 86. The relationship of thyrotropin receptor antibody levels to the severity of thyroid orbitopathy.
    Shokeir MO; Pudek MR; Katz S; Rootman J; Kendler DL
    Clin Biochem; 1996 Apr; 29(2):187-9. PubMed ID: 8601331
    [No Abstract]   [Full Text] [Related]  

  • 87. Immuno-localisation of anti-thyroid antibodies in adult human cerebral cortex.
    Moodley K; Botha J; Raidoo DM; Naidoo S
    J Neurol Sci; 2011 Mar; 302(1-2):114-7. PubMed ID: 21196016
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Age May Influence the Impact of TRAbs on Thyroid Function and Relapse-Risk in Patients With Graves Disease.
    Bano A; Gan E; Addison C; Narayanan K; Weaver JU; Tsatlidis V; Razvi S
    J Clin Endocrinol Metab; 2019 May; 104(5):1378-1385. PubMed ID: 30517711
    [TBL] [Abstract][Full Text] [Related]  

  • 89. [Effect of carbimazole and dexamethasone on the TSH bond (TBII) inhibiting immunoglobulins in Graves-Basedow disease].
    Obiols Alfonso G; Mesa Manteca J; Simó Canonge R; García Pascual L; García Alonso C; Tresánchez Trías JM
    Rev Clin Esp; 1988 Nov; 183(8):401-4. PubMed ID: 2906163
    [No Abstract]   [Full Text] [Related]  

  • 90. Concomitant association of thyroid sarcoidosis and Graves' disease.
    Yarman S; Kahraman H; Tanakol R; Kapran Y
    Horm Res; 2003; 59(1):43-6. PubMed ID: 12566735
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The circadian variation of thyrotrophin in patients with primary thyroidal disease.
    Evans PJ; Weeks I; Jones MK; Woodhead JS; Scanlon MF
    Clin Endocrinol (Oxf); 1986 Apr; 24(4):343-8. PubMed ID: 3755657
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Measurement of TSH-binding--inhibiting immunoglobulins (TBII) using a radioreceptor-assay (TRAK) in patients with and without thyroid disease.
    Heberling HJ; Bierwolf B; Kuhlmann E; Lohmann D
    Radiobiol Radiother (Berl); 1987; 28(5):582-5. PubMed ID: 2894706
    [No Abstract]   [Full Text] [Related]  

  • 93. [A new technic for determining anti-TSH receptor antibodies: the TBIAb assay].
    Gheri RG; Biagioni M; Forni S; Vannucchi CE; Mazzoni M; Prussi E
    Boll Soc Ital Biol Sper; 1987 Apr; 63(4):327-31. PubMed ID: 2896007
    [No Abstract]   [Full Text] [Related]  

  • 94. TSH receptor activation and body composition.
    de Lloyd A; Bursell J; Gregory JW; Rees DA; Ludgate M
    J Endocrinol; 2010 Jan; 204(1):13-20. PubMed ID: 19759194
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Spuriously high thyrotropin values due to anti-thyrotropin antibodies in adult patients.
    Verhoye E; Van den Bruel A; Delanghe JR; Debruyne E; Langlois MR
    Clin Chem Lab Med; 2009; 47(5):604-6. PubMed ID: 19397486
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Unusual evolution of autoimmune hypothyroidism: occurrence of Grave's disease].
    Le Berre JP; Rousseau C; Dupuy O; Bordier L; Mayaudon H; Bauduceau B
    Rev Med Interne; 2004 Nov; 25(11):841-3. PubMed ID: 15501358
    [No Abstract]   [Full Text] [Related]  

  • 97. Proceedings: The thyroid-stimulating hormone receptor and thyroid-stimulating antibodies.
    Smith BR; Hall R
    J Endocrinol; 1974 Nov; 63(2):59P-60P. PubMed ID: 4374495
    [No Abstract]   [Full Text] [Related]  

  • 98. Measurement of TSH Receptor Epitope-Specific T Cells in Graves' Disease.
    Allelein S; Kuebart A; Haase M; Dringenberg T; Schmid C; Schott M; Ehlers M
    Horm Metab Res; 2016 Dec; 48(12):862-864. PubMed ID: 27923251
    [No Abstract]   [Full Text] [Related]  

  • 99. Transient Graves disease developing after surgery for Cushing disease.
    Morita H; Isaji M; Mune T; Daido H; Isomura Y; Sarui H; Tanahashi T; Takeda N; Ishizuka T; Yasuda K
    Am J Med Sci; 2002 Mar; 323(3):162-5. PubMed ID: 11908863
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Within-Person Variation in Serum Thyrotropin Concentrations: Main Sources, Potential Underlying Biological Mechanisms, and Clinical Implications.
    van der Spoel E; Roelfsema F; van Heemst D
    Front Endocrinol (Lausanne); 2021; 12():619568. PubMed ID: 33716972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.